Jim Simons An2 Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 368,708 shares of ANTX stock, worth $387,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
368,708
Previous 579,773
36.4%
Holding current value
$387,143
Previous $788,000
36.42%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANTX
# of Institutions
37Shares Held
13.6MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$6.04 Million6.33% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.38 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.09 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1MShares$1.05 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY581KShares$609,8950.89% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $20.4M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...